Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Microbiology and prognostic factors of hospital- and community-acquired aspiration pneumonia in respiratory intensive care unit.

Wei C, Cheng Z, Zhang L, Yang J.

Am J Infect Control. 2013 Oct;41(10):880-4. doi: 10.1016/j.ajic.2013.01.007. Epub 2013 Mar 22. Erratum in: Am J Infect Control. 2014 Jan;42(1):91.

PMID:
23523524
2.

A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP).

Fukuyama H, Yamashiro S, Tamaki H, Kishaba T.

J Infect Chemother. 2013 Aug;19(4):719-26. doi: 10.1007/s10156-013-0557-1. Epub 2013 Jan 25.

PMID:
23354936
3.

Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia.

Wu CL, Lee YL, Chang KM, Chang GC, King SL, Chiang CD, Niederman MS.

Crit Care Med. 2003 Mar;31(3):812-7.

PMID:
12626989
4.

Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.

Falguera M, Carratalà J, Ruiz-Gonzalez A, Garcia-Vidal C, Gazquez I, Dorca J, Gudiol F, Porcel JM.

Respirology. 2009 Jan;14(1):105-11. doi: 10.1111/j.1440-1843.2008.01371.x.

PMID:
18699803
5.

[Adult hospital acquired pneumonia: a multicenter study on microbiology and clinical characteristics of patients from 9 Chinese cities].

Liu YN, Cao B, Wang H, Chen LA, She DY, Zhao TM, Liang ZX, Sun TY, Li YM, Tong ZH, Wang Z, He B, Yang W, Qu JM, Li XY, Chen RC, Ye F, Kang J, Li ER, Chen P, Zheng Y, Ma ZS, Ren J, Shi Y, Sun WK, Feng YL, Fan H, Jiang SJ, Zhang S, Xiong SD, Zuo P, Wang ZW.

Zhonghua Jie He He Hu Xi Za Zhi. 2012 Oct;35(10):739-46. Chinese.

PMID:
23289990
6.

Community-acquired aspiration pneumonia in intensive care units. Epidemiological and prognosis data.

Leroy O, Vandenbussche C, Coffinier C, Bosquet C, Georges H, Guery B, Thevenin D, Beaucaire G.

Am J Respir Crit Care Med. 1997 Dec;156(6):1922-9.

PMID:
9412576
7.

[Prognostic factors and etiology in patients with severe community-acquired pneumonia admitted at the ICU. Spanish multicenter study. Study Group on Severe Community-Acquired Pneumonia in Spain].

Alvarez-Sánchez B, Alvarez-Lerma F, Jordà R, Serra J, López-Cambra MJ, Sandar MD.

Med Clin (Barc). 1998 Nov 21;111(17):650-4. Spanish.

PMID:
9881346
8.

[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].

Vitkauskiene A, Sakalauskas R, Dudzevicius V.

Medicina (Kaunas). 2003;39(3):254-9. Lithuanian.

9.

Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia.

Aliberti S, Di Pasquale M, Zanaboni AM, Cosentini R, Brambilla AM, Seghezzi S, Tarsia P, Mantero M, Blasi F.

Clin Infect Dis. 2012 Feb 15;54(4):470-8. doi: 10.1093/cid/cir840. Epub 2011 Nov 21.

PMID:
22109954
10.

[Guidelines for treatment of pneumonia in intensive care units].

Emmi V.

Infez Med. 2005;Suppl:7-17. Review. Italian.

11.

Community-acquired pneumonia in the intensive care unit: epidemiological and prognosis data in older people.

Leroy O, Bosquet C, Vandenbussche C, Coffinier C, Georges H, Guery B, Alfandari S, Thevenin D, Beaucaire G.

J Am Geriatr Soc. 1999 May;47(5):539-46.

PMID:
10323646
12.

Community- and hospital-acquired pneumonia in medical intensive care unit.

Limthongkul S, Charoenlap P.

J Med Assoc Thai. 1993 Mar;76(3):129-37.

PMID:
8228708
13.
14.

Community acquired infections in older patients admitted to hospital from care homes versus the community: cohort study of microbiology and outcomes.

Marwick C, Santiago VH, McCowan C, Broomhall J, Davey P.

BMC Geriatr. 2013 Feb 6;13:12. doi: 10.1186/1471-2318-13-12.

15.

Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.

Lee H, Park JY, Lee T, Lee YJ, Lim HJ, Park JS, Yoon HI, Lee JH, Lee CT, Cho YJ.

Korean J Intern Med. 2016 May;31(3):525-34. doi: 10.3904/kjim.2015.103. Epub 2016 Mar 11.

16.

The impact of Candida isolates on the outcome of aspiration pneumonia.

Lin HL, Chao CM, Lai CC.

Am J Infect Control. 2013 Sep;41(9):850-1. doi: 10.1016/j.ajic.2013.04.021. No abstract available.

PMID:
23993763
17.

[Prospective observational study of pneumonia in an Italian hospital].

Sacchetti R, Aporti M, Bianco L, Lazzari C, Legnani PP, Zanetti F, Finzi GF, Leoni E.

Infez Med. 2008 Dec;16(4):219-26. Italian.

18.

[The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].

Wei HJ, Liu LL, Xiaoli LY, Wang YP, Huang D, Pian HY, Zhu YC.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009 Jan;21(1):36-9. Chinese.

19.

Reply: the impact of Candida isolates on the outcome of aspiration pneumonia.

Wei C, Cheng Z, Zhang L, Yang J.

Am J Infect Control. 2013 Sep;41(9):851. doi: 10.1016/j.ajic.2013.06.003. No abstract available.

PMID:
23993764
20.

Pneumonia observational incidence and treatment: a multidisciplinary process improvement study.

Brozek J, McDonald E, Clarke F, Gosse C, Jaeschke R, Cook D.

Am J Crit Care. 2007 May;16(3):214-9.

Supplemental Content

Support Center